Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaron Carmi

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Oncotarget|October 13, 2015
Tumor-binding antibodies and tumor immunityYaron Carmi, Edgar G Engleman
International Journal of Cell Biology|January 14, 2017
Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and LimitationsPeleg Rider, Yaron Carmi, Idan Cohen
Frontiers in Immunology|May 16, 2022
Editorial: Implementing Logic Gates in Adoptive Cell TherapyGideon Gross, Yaron Carmi, Hinrich Abken
Frontiers in Physiology|April 16, 2014
The role IL-1 in tumor-mediated angiogenesisElena Voronov, Yaron Carmi, Ron N Apte
Oncoimmunology|October 25, 2019
Tumor-binding antibodies induce potent dendritic cell-mediated tumor immunityYaron Carmi, Tyler Prestwood, Edgar G Engleman
Advances in Experimental Medicine and Biology|August 24, 2007
Role of IL-1-mediated inflammation in tumor angiogenesisElena Voronov, Yaron Carmi, Ron N Apte
Oncotarget|August 12, 2021
Tumor-reactive T cells are licensed by dendritic cells located in spatially different tissues: implications for dendritic cell vaccinesNadine Santana-Magal, Leen Farhat-Younis, Yaron Carmi
Seminars in Immunology|November 5, 2013
Interleukin-1αPeleg Rider, Yaron Carmi, Elena Voronov, et al.
Frontiers in Immunology|August 5, 2021
Antibody Repertoire Analysis of Tumor-Infiltrating B Cells Reveals Distinct Signatures and Distributions Across TissuesLigal Aizik, Yael Dror, David Taussig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2011
Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasisYaron Carmi, Gal Rinott, Shahar Dotan, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Oncotarget|October 13, 2015
Tumor-binding antibodies and tumor immunityYaron Carmi, Edgar G Engleman
International Journal of Cell Biology|January 14, 2017
Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and LimitationsPeleg Rider, Yaron Carmi, Idan Cohen
Frontiers in Immunology|May 16, 2022
Editorial: Implementing Logic Gates in Adoptive Cell TherapyGideon Gross, Yaron Carmi, Hinrich Abken
Frontiers in Physiology|April 16, 2014
The role IL-1 in tumor-mediated angiogenesisElena Voronov, Yaron Carmi, Ron N Apte
Oncoimmunology|October 25, 2019
Tumor-binding antibodies induce potent dendritic cell-mediated tumor immunityYaron Carmi, Tyler Prestwood, Edgar G Engleman
Advances in Experimental Medicine and Biology|August 24, 2007
Role of IL-1-mediated inflammation in tumor angiogenesisElena Voronov, Yaron Carmi, Ron N Apte
Oncotarget|August 12, 2021
Tumor-reactive T cells are licensed by dendritic cells located in spatially different tissues: implications for dendritic cell vaccinesNadine Santana-Magal, Leen Farhat-Younis, Yaron Carmi
Seminars in Immunology|November 5, 2013
Interleukin-1αPeleg Rider, Yaron Carmi, Elena Voronov, et al.
Frontiers in Immunology|August 5, 2021
Antibody Repertoire Analysis of Tumor-Infiltrating B Cells Reveals Distinct Signatures and Distributions Across TissuesLigal Aizik, Yael Dror, David Taussig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2011
Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasisYaron Carmi, Gal Rinott, Shahar Dotan, et al.
Pageof 6